These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 21514369

  • 1. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?
    Dragicevic N, Bradshaw PC, Mamcarz M, Lin X, Wang L, Cao C, Arendash GW.
    Neuroscience; 2011 Jun 30; 185():135-49. PubMed ID: 21514369
    [Abstract] [Full Text] [Related]

  • 2. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC.
    J Alzheimers Dis; 2010 Jun 30; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [Abstract] [Full Text] [Related]

  • 3. Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit.
    Arendash GW, Mori T, Dorsey M, Gonzalez R, Tajiri N, Borlongan C.
    PLoS One; 2012 Jun 30; 7(4):e35751. PubMed ID: 22558216
    [Abstract] [Full Text] [Related]

  • 4. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 5. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S, Bose S, Hur J, Jun K, Kim YK, Cho KS, Koo BS.
    J Ethnopharmacol; 2011 Sep 01; 137(1):783-9. PubMed ID: 21762767
    [Abstract] [Full Text] [Related]

  • 6. Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice.
    Arendash GW, Sanchez-Ramos J, Mori T, Mamcarz M, Lin X, Runfeldt M, Wang L, Zhang G, Sava V, Tan J, Cao C.
    J Alzheimers Dis; 2010 Sep 01; 19(1):191-210. PubMed ID: 20061638
    [Abstract] [Full Text] [Related]

  • 7. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.
    Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, Trillat AC, Stern DM, Arancio O, Yan SS.
    FASEB J; 2005 Apr 01; 19(6):597-8. PubMed ID: 15665036
    [Abstract] [Full Text] [Related]

  • 8. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H.
    Neuroscience; 2007 Oct 26; 149(2):286-302. PubMed ID: 17904756
    [Abstract] [Full Text] [Related]

  • 9. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
    Dragicevic N, Copes N, O'Neal-Moffitt G, Jin J, Buzzeo R, Mamcarz M, Tan J, Cao C, Olcese JM, Arendash GW, Bradshaw PC.
    J Pineal Res; 2011 Aug 26; 51(1):75-86. PubMed ID: 21355879
    [Abstract] [Full Text] [Related]

  • 10. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J.
    Neuroscience; 2006 Nov 03; 142(4):941-52. PubMed ID: 16938404
    [Abstract] [Full Text] [Related]

  • 11. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
    Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H.
    J Alzheimers Dis; 2009 Nov 03; 17(3):661-80. PubMed ID: 19581722
    [Abstract] [Full Text] [Related]

  • 12. Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development.
    Arendash GW.
    J Alzheimers Dis; 2012 Nov 03; 32(2):243-66. PubMed ID: 22810103
    [Abstract] [Full Text] [Related]

  • 13. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Nov 03; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 14. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice.
    Cao C, Wang L, Lin X, Mamcarz M, Zhang C, Bai G, Nong J, Sussman S, Arendash G.
    J Alzheimers Dis; 2011 Nov 03; 25(2):323-35. PubMed ID: 21422521
    [Abstract] [Full Text] [Related]

  • 15. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A.
    Yang L, Ye CY, Huang XT, Tang XC, Zhang HY.
    J Alzheimers Dis; 2012 Nov 03; 31(1):131-42. PubMed ID: 22531425
    [Abstract] [Full Text] [Related]

  • 16. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
    Kummer MP, Hermes M, Delekarte A, Hammerschmidt T, Kumar S, Terwel D, Walter J, Pape HC, König S, Roeber S, Jessen F, Klockgether T, Korte M, Heneka MT.
    Neuron; 2011 Sep 08; 71(5):833-44. PubMed ID: 21903077
    [Abstract] [Full Text] [Related]

  • 17. 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice.
    Jeong YJ, Kang GY, Kwon JH, Choi HD, Pack JK, Kim N, Lee YS, Lee HJ.
    Curr Alzheimer Res; 2015 Sep 08; 12(5):481-92. PubMed ID: 26017559
    [Abstract] [Full Text] [Related]

  • 18. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
    Umeda T, Tomiyama T, Kitajima E, Idomoto T, Nomura S, Lambert MP, Klein WL, Mori H.
    Life Sci; 2012 Dec 10; 91(23-24):1169-76. PubMed ID: 22273754
    [Abstract] [Full Text] [Related]

  • 19. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
    Hauptmann S, Scherping I, Dröse S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Müller WE.
    Neurobiol Aging; 2009 Oct 10; 30(10):1574-86. PubMed ID: 18295378
    [Abstract] [Full Text] [Related]

  • 20. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
    Hwang SH, Shin EJ, Shin TJ, Lee BH, Choi SH, Kang J, Kim HJ, Kwon SH, Jang CG, Lee JH, Kim HC, Nah SY.
    J Alzheimers Dis; 2012 Oct 10; 31(1):207-23. PubMed ID: 22543851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.